Cancer immunotherapy .net
Information on human tumours
pilot studies 2
tumour type
Results in brief:

2 patients treated; mesothelioma in 1

Research in progress
Paper above describing beneficial results for 1 patient with mesothelioma
Krastev et al. (2001) Cancer Immunol. Immunother. 50, 226

Paper describing non-beneficial results for 1 patient with mesothelioma and 15 patients with other abdominal cancers
Krastev et al. (2005) World J. Gastroenterol. 11, 5525
tumour type
Interleukin-2 (IL-2)
Mechanism of IL-2 therapy of cancer

Cancers sensitve to IL-2
Surgery and IL-2
Radiotherapy and IL-2
Chemotherapy and IL-2

I want to co-operate (doctors)
Frequently Asked Questions (FAQs)
Information for doctors
Information for patients
I want to support this research or  more information on the EPTI fund supporting this research
Our research is supported by Stichting ter bevordering van het onderzoek in de Experimentele Pathologie en in het bijzonder in de TumourImmunologie. Stichting EPTI, IJselstein, The Netherlands